Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A mLifestyle Intervention for Men on Androgen Deprivation Therapy for PCa
NCT07462403 · View on ClinicalTrials.gov ↗
Study Summary
Participants in the study will have weekly phone calls with a trained health coach. During these calls, they will receive guidance on extending their overnight fasting time-starting with at least 12 hours and slowly working toward 16 hours each night. Participants will also use a text-message system to report when they start and stop fasting and to share information about their sleep. The system will send encouraging messages when they meet their fasting goals, along with tips and helpful reminders. Healthy Eating Attention Control Group: Participants in this group will receive two text messages each day with simple, evidence-based information and tips on healthy eating. These messages are based on materials from the American Institute for Cancer Research (AICR).
Conditions Studied
Interventions
- BEHAVIORAL mLifestyle
- BEHAVIORAL Healthy Diet Text Messaging
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital — Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2024-05-02 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07462403
The ClinicalTrials.gov registry entry for NCT07462403 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 324 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions — of which mLifestyle is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT07462403 reports 1 study location spanning 1 distinct geographic area — top geographies include Pennsylvania. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT07462403 about?
NCT07462403 is a clinical study titled "A mLifestyle Intervention for Men on Androgen Deprivation Therapy for PCa". Participants in the study will have weekly phone calls with a trained health coach. During these calls, they will receive guidance on extending their overnight fasting time-starting with at least 12 hours and slowly working toward 16 hours each night. Participants will also use a text-message system...
What is the current status of trial NCT07462403?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2024-05-02. Estimated completion is 2026-12-31.
What conditions does trial NCT07462403 study?
This clinical trial studies the following conditions: Prostate Cancer. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT07462403?
The interventions under investigation include: mLifestyle (BEHAVIORAL), Healthy Diet Text Messaging (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT07462403?
This trial is sponsored by Thomas Jefferson University, which has 324 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT07462403 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.